Recursion Pharmaceuticals RXRX Price Prediction

The determination to procure Recursion Pharmaceuticals is entirely contingent on your individualistic risk tolerance. As you may discern, Recursion Pharmaceuticals's value has experienced an escalation of 0.97% during the preceding 24 hours, and Recursion Pharmaceuticals has incurred a decline of -9.96% over the prior 30-day duration. Consequently, the determination of whether or not to invest in Recursion Pharmaceuticals will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of Recursion Pharmaceuticals may potentially surge to $4.45 by the end of this year. Looking at Recursion Pharmaceuticals's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $5.09. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental Recursion Pharmaceuticals forecast, the price of Recursion Pharmaceuticals will increase by 1.74% over the next week and reach $4.23 by November 26, 2025.

Based on the our new experimental Recursion Pharmaceuticals forecast, the price of Recursion Pharmaceuticals will increase by 3.04% over the next month and reach $4.29 by December 19, 2025.

As per our most recent prediction on Recursion Pharmaceuticals's value in 2025, RXRX is anticipated to fluctuate within the range of $4.17 and $4.45. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected Recursion Pharmaceuticals price forecast fails to consider sudden and extreme price fluctuations.

Recursion Pharmaceuticals's future appears to be on an upward trend, with an maximum price of $5.09 projected after a period of five years. Based on the Recursion Pharmaceuticals forecast for 2030, Recursion Pharmaceuticals's value may potentially reach its highest peak of approximately $5.09, while its lowest peak is anticipated to be around $4.27.

Based on the our new experimental Recursion Pharmaceuticals price prediction simulation, RXRX’s value in 2025 expected to grow by 7.07% to $4.45 if the best happened. The price will be between $4.45 and $4.17 during 2025.

According to our latest experimental simulation for Recursion Pharmaceuticals price prediction, RXRX’s value could rise by 27.78% to $5.31 in 2026, assuming the most favorable conditions. The price is projected to fluctuate between $5.31 and $4.44 throughout the year.

Our new experimental Recursion Pharmaceuticals price prediction model suggests that RXRX’s value in 2027 could increase by 32.66% , reaching $5.51 in the best-case scenario. The price is expected to range between $5.51 and $4.79 during the year.

Based on our experimental forecast model, Recursion Pharmaceuticals's value may experience a 19.76% growth in 2028, potentially reaching $4.98 under optimal conditions. The predicted price range for 2028 lies between $4.98 and $4.04.

Using our new experimental simulation for Recursion Pharmaceuticals price predictions, RXRX’s value in 2029 is expected to rise by 9.78% , reaching $4.56 in the best scenario. The price is forecasted to range between $4.56 and $4.05 over the course of 2029.

Our experimental simulation indicates that Recursion Pharmaceuticals’s price could grow by 22.37% in 2030, potentially hitting $5.09 under ideal conditions. The price will likely fluctuate between $5.09 and $4.27 during the year.

Based on the findings from our latest experimental Recursion Pharmaceuticals price prediction, RXRX could see a 26.58% rise in value, reaching $5.26 if the most positive scenario plays out in 2031. The price is expected to stay within a range of $5.26 and $4.87 throughout the year.

According to our experimental Recursion Pharmaceuticals price prediction, RXRX’s value is anticipated to rise by 41.06% in 2032, with the highest potential price being $5.86. Throughout the year, RXRX’s price could range from $5.86 and $5.17.

The results from our new Recursion Pharmaceuticals price prediction simulation suggest that RXRX may rise by 62.43% in 2033, potentially reaching $6.75 under the best circumstances. The predicted price range for the year is between $6.75 and $5.88.

Based on our experimental forecast for Recursion Pharmaceuticals’s price, RXRX could grow by 78.23% , with the value potentially hitting $7.41 in 2034. The expected price range for the year lies between $7.41 and $6.57.

Our recent Recursion Pharmaceuticals price prediction simulation suggests that RXRX’s value might rise by 104.45% in 2035, possibly reaching $8.50 if conditions are optimal. The expected price range for 2035 is between $8.50 and $7.13.

According to the experimental simulation, Recursion Pharmaceuticals’s value could rise by 152.16% in 2036, with a high of $10.48 under favorable conditions. The price is expected to fall between $10.48 and $8.23 over the course of the year.